Multiple myeloma is a blood cancer that starts in plasma cells, a type of white blood cell found in the bone marrow. Normally, plasma cells produce antibodies that fight infections. In myeloma, these cells turn cancerous and multiply out of control, crowding out healthy blood cells and producing abnormal proteins that can damage organs.
Because myeloma affects the bone marrow, it can weaken bones, strain the kidneys, and compromise the immune system all at once. Think of it like a factory that starts mass-producing faulty parts while shutting down the good production lines.
Treatment has improved over the past two decades, and many patients live for years with proper management. Put simply, myeloma is currently considered treatable but not curable for most patients.
The goal is to control the disease, manage symptoms, and maintain quality of life for as long as possible. Actually, newer therapies like immunotherapy and targeted drugs have extended survival meaningfully compared to a generation ago.
It's not among the most common cancers overall, but it's the second most common blood cancer. In India, myeloma incidence has been rising, partly because diagnostic capabilities have improved and partly because life expectancy has increased.
First, many cases in India are still diagnosed at advanced stages because early symptoms get attributed to aging or arthritis.
Second, awareness among general practitioners remains lower than it should be, especially in smaller cities.
Not all myelomas behave the same way. The type of multiple myeloma shapes the treatment approach and expected progression:
Multiple Myeloma Cancer Stages depend on several key measurements. It's a bit like reading multiple gauges on a dashboard to understand the overall engine condition:
If you're experiencing persistent bone pain, unexplained fatigue, frequent infections, or kidney problems that don't respond to standard treatment, it's time to see a specialist.
And if routine blood tests show abnormal protein levels or low blood counts, that warrants further investigation. The honest answer is that a simple blood test can flag myeloma-related changes early.
Symptoms and causes of multiple myeloma are closely linked to several risk factors. Adults over 60 face the highest risk, and the disease is more common in men than women. In most cases, though not all, multiple myeloma develops gradually from a precursor condition called MGUS.
And what many doctors won't say outright is that many patients live with MGUS for years without knowing it, and only a small percentage progress to active myeloma.
Symptoms can be vague and develop slowly, which is why myeloma often gets caught later than it should. Roughly speaking, most symptoms come from the cancer's effects on bones, blood, kidneys, and the immune system:
The exact cause isn't fully understood, but several factors raise the odds:
Persistent bone pain, especially in the spine or ribs, along with fatigue and frequent infections, should prompt a visit to a specialist. Most oncologists agree that early hematology referral gives patients more treatment options before complications set in.
A myeloma diagnosis doesn't come from a single test. First, blood and urine tests detect abnormal proteins. Second, imaging reveals bone damage. Third, a bone marrow biopsy confirms the diagnosis and provides information about the cancer's biology. Think of it as assembling evidence from multiple angles.
Treatment depends on the stage, risk profile, and overall health. Or rather, the treatment options for myeloma have expanded considerably, and today's patients have more options than ever before.
But the best approach often combines multiple therapies working together:
Hematologists and oncologists at HCG Cancer Hospital in Bengaluru, Mumbai, Ahmedabad, and Kolkata handle multiple myeloma from initial protein screening through treatment and long-term monitoring. The honest answer is that myeloma management requires specialized hematology expertise.
And HCG Cancer Hospital's transplant program and access to newer therapies like CAR-T cell treatment give patients options that aren't available at every center.
What you eat won't cure myeloma, but it supports overall health during treatment. Think of nutrition as giving your body the best raw materials to work with:
Myeloma and its treatment weaken the immune system, which means food safety matters more than usual. Well, almost always the concern is about avoiding infections from contaminated food:
People over 60, men, those with a family history of myeloma, and individuals with a prior diagnosis of MGUS face the highest risk. In India, late diagnosis remains common because many patients and doctors don't connect bone pain and fatigue with a blood cancer.
If you've got multiple risk factors, discussing regular screening with a hematologist can help catch changes before they progress to active myeloma.
Multiple myeloma is a serious but treatable blood cancer. It's a bit like managing a long-term condition where the right treatment team and early intervention make a meaningful difference. Patients who receive care at specialized centers like HCG Cancer Hospital benefit from access to the latest therapies and structured monitoring plans.
Feel free to reach out to us.
